🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with mash biomarker panel? Page 6

Has anyone dealt with mash biomarker panel?

Dr.ObesityMed Mon, Jul 22, 2024 at 9:09 PM 27 replies 2,236 viewsPage 6 of 6
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Aug 18, 2024 at 11:17 PM#26
Dr.SportsMedIN said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.

18 16Dr.LeslieOBGYN, MikeNYC_runner and 15 others
Reply Quote Save Share Report
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Aug 21, 2024 at 10:13 PM#27

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

19 17NicoleRaleigh, james_edin, FranDenver and 16 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Aug 24, 2024 at 9:07 PM#28

A narrower follow-up, since the general answer is now clear:

How often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning?

20 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 17 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Aug 27, 2024 at 7:59 PM#29
dave_SLC said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

Correct me if the detail matters more than I have assumed.

21 19DanielChem_CHI, marco_milano, pam_columbus and 18 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Aug 30, 2024 at 6:50 PM#30

Closing the loop on my own question.

Resolved, and the thing that resolved it was the least interesting suggestion in the thread. Writing that down for the next person who wants the interesting answer.

43 16A1cHero_PHX, Dr.RenalNash, LipidDoc_ATL and 40 others
Reply Quote Save Share Report
1456

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register